just looking at the SIOI relationship. we had this presented...

just looking at the SIOI relationship. we had this presented this week





anteotech has the $1.8m/5 year commercial deal which has already been expanded upon. mainly for vaccine testing. but from above we have diversion of product usage.

we had Merrill state SIOI are looking at lateral flow development. we have papers on our website from SIOI showing anteobind/SIOI relationship in this



the components of the assay being nearly the same as a new vaccine SIOI is testing



now here is a new bit. I posted this paper from India about extracellular vesicle testing a few weeks ago 78663546

and another post 78588507

then what could ev  be used for



what has this to do with SIOI



so just to summarise

SIOI are expanding the uses of anteobind. we know with vaccines testing/development (?) , with lateral flow development and maybe with ev tech.

so what is happening

"A visit by SII executives to Brisbane is planned in May 2025"

this is different from anteo visiting them, we are trying to sell them something. why would SII executives visit anteo hq?

could this be a clue

" along with potential monetisation opportunities via strategic or corporate partnerships."

SII have been buying and investing in companies with complimentary tech and do love a photo app at these events.

maybe / maybe not. just something to think about short term !!!! at the minimum, the use of ev's and anteobind shows a huge potential market for anteotech

GLTAH